what is glucagon-like peptide-1 a hormone produced in the gut and released in response to food - Glucagon-like peptide-1structure a hormone produced in the gut and released in response to food

Glucagon-like peptideexamples

What is Glucagon-Like Peptide-1 (GLP-1)?

Glucagon-like peptide-1 (GLP-1) is a crucial hormone naturally produced in the gut, playing a significant role in regulating blood sugar levels and influencing appetite. This peptide hormone, derived from the proglucagon molecule, is released in response to food intake and acts as an incretin, a class of substances that stimulate insulin secretion.Glucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI Understanding what GLP-1 is and how it functions is key to comprehending its impact on metabolic health and its therapeutic applications.

The Physiology and Function of GLP-1

GLP-1 is a 30-amino acid peptide hormone synthesized and secreted by specialized endocrine L-cells located in the intestinal lining. Its release is primarily triggered by the presence of nutrients in the digestive tract, particularly carbohydrates and fats.作者：JJ Holst·2007·被引用次数：4286—GLP-1 is a 30-amino acid peptide hormoneproduced in the intestinal epithelial endocrine L-cells by differential processing of proglucagon. Once released into the bloodstream, GLP-1 exerts several beneficial physiological effects:

* Stimulates Insulin Release: GLP-1 enhances glucose-dependent insulin secretion from the pancreatic beta cells. This means it promotes insulin release when blood glucose levels are high, helping to lower them, but it does not typically cause hypoglycemia when glucose levels are normal or low.

* Suppresses Glucagon Secretion: It also inhibits the release of glucagon, another hormone produced by the pancreas that raises blood glucose levels. By reducing glucagon, GLP-1 further contributes to blood sugar control.Glucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI

* Slows Gastric Emptying: GLP-1 can slow down the rate at which food leaves the stomach, leading to a more gradual absorption of nutrients and a prolonged feeling of fullness.

* Reduces Appetite: By acting on the brain, GLP-1 can decrease appetite and increase satiety, contributing to reduced food intake.

* Protects Beta Cells: Emerging research suggests GLP-1 may have protective effects on pancreatic beta cells, potentially promoting their survival and function.Glucagon-like peptide-1

GLP-1 Receptor Agonists: Therapeutic Applications

The body's natural production of GLP-1 is relatively short-lived due to rapid degradation by an enzyme called dipeptidyl peptidase-4 (DPP-4)作者：TD Müller·2019·被引用次数：1891—The glucagon-like peptide-1 (GLP-1) isa multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects of GLP-1 are the .... This limitation led to the development of GLP-1 receptor agonists (GLP-1 RAs), a class of medications that mimic the actions of the native hormone but are designed to be more resistant to degradation, offering a longer duration of effectComparing Ozempic, Wegovy and Other GLP-1 Drugs.

GLP-1 receptor agonists have become highly effective treatments for:

* Type 2 Diabetes: By improving glycemic control through enhanced insulin secretion and reduced glucagon release, these medications help manage blood sugar levels in individuals with type 2 diabetes.

* Obesity and Weight Management: Due to their appetite-suppressing and satiety-promoting effects, GLP-1 RAs have proven to be valuable tools for weight loss in individuals with obesity. Medications like semaglutide, originally developed for diabetes, are now widely prescribed for weight management.

These drugs work by binding to GLP-1 receptors, initiating the same signaling pathways as the natural hormone作者：JJ Holst·2007·被引用次数：4290—Glucagon-like peptide 1 (GLP-1) is a 30-amino acid peptide hormone produced in the intestinal epithelial endocrine L-cells by differential .... Their efficacy in managing both blood glucose and body weight has revolutionized treatment paradigms for these conditions.作者：K Dungan·被引用次数：37—GLP-1 stimulates glucose-dependent insulin release from the pancreatic islets[1]. It also slows gastric emptying [4], inhibits inappropriate ...

Where GLP-1 is Found and Its Structure

GLP-1 is primarily found in the enteroendocrine L-cells of the small and large intestines2018年12月13日—Glucagon-like peptide 1 (GLP-1) is likely best known by many readers of Diabetes because of the role it plays in insulin secretion.. It is also detected in the brain, suggesting a role in central appetite regulationGlucagon-like peptide-1 receptor agonists for obesity. The hormone exists in different forms, with the most common being a 30-amino acid peptide. Its structure is closely related to glucagon, hence the name "glucagon-like peptide.作者：L Collins·2024·被引用次数：332—Glucagon-like peptide-1(GLP-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (T2DM) and obesity." This structural similarity is a key aspect of its identity and function. The specific processing of the proglucagon gene results in the production of various peptides, including GLP-1.

Understanding GLP-1 Medications and Their Impact

The advent of GLP-1 agonist drugs has brought significant advancements in metabolic disease management. Beyond their primary roles in diabetes and weight loss, these medications have been associated with cardiovascular benefits in some patient populations. However, like all medications, GLP-1 RAs can have side effects, which may include gastrointestinal issues such as nausea and vomiting.Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon ... Concerns have also been raised regarding potential risks like suicidal behavior and ideation, leading to ongoing monitoring and regulatory guidance作者：T Bu·被引用次数：91—ABSTRACT. Glucagon-like peptide-1 (GLP-1)is a 30-amino acid peptide hormonethat is mainly expressed in the intestine and hypothalamus..

When individuals stop taking GLP-1 drugs, they may experience a rebound in appetite and a potential regain of lost weight, alongside a possible worsening of glycemic control. This underscores the importance of sustained treatment for managing chronic conditions like type 2 diabetes and obesity.

In summary, glucagon-like peptide-1 is a vital gut hormone with multifaceted roles in glucose homeostasis, appetite regulation, and digestion. Its physiology has paved the way for innovative therapeutic strategies, particularly GLP-1 receptor agonists, which offer significant benefits for individuals managing type 2 diabetes and obesity.